Radiko Holdings Corp. Aktie Canadian Securities Exchange
Aktien
A2QAAM
CA75034R1029
JUJU
Pharmazeutika
Umsatz 2018 | 106’584 145’210 96’060.96 | Umsatz 2019 | 5.18 Mio. 7.06 Mio. 4.67 Mio. | Marktwert | 6.17 Mio. 8.4 Mio. 5.56 Mio. |
---|---|---|---|---|---|
Nettoergebnis 2018 | -4 Mio. -5.45 Mio. -3.61 Mio. | Nettoergebnis 2019 | -10 Mio. -13.62 Mio. -9.01 Mio. | EV / Sales 2018 | 101 x |
Nettoschuld 2018 | 258’657 352’394 233’120 | Nettoschuld 2019 | 1.98 Mio. 2.7 Mio. 1.79 Mio. | EV / Sales 2019 | 1.57 x |
KGV 2018 |
-1.5
x | KGV 2019 |
-0.53
x | Beschäftigte | - |
Rendite 2018 * |
-
| Rendite 2019 |
-
| Streubesitz | 96.73% |
Manager | Titel | Alter | Seit |
---|---|---|---|
Steven Gormley
CEO | Chief Executive Officer | 55 | 16.04.18 |
David Rosenberg
CTO | Chief Tech/Sci/R&D Officer | - | 10.12.19 |
Scott Reeves
BRD | Director/Board Member | 55 | 01.02.17 |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Steven Gormley
CEO | Chief Executive Officer | 55 | 16.04.18 |
Scott Reeves
BRD | Director/Board Member | 55 | 01.02.17 |
Robert Yosaitis
BRD | Director/Board Member | - | 12.11.19 |
% 1. Jan. | Kap. | |
---|---|---|
+40.73% | 739 Mrd. | |
+32.83% | 598 Mrd. | |
-6.30% | 353 Mrd. | |
+15.15% | 318 Mrd. | |
+4.05% | 285 Mrd. | |
+15.00% | 240 Mrd. | |
+9.78% | 210 Mrd. | |
-5.52% | 206 Mrd. | |
+6.17% | 164 Mrd. |